Detalles de la búsqueda
1.
Conditioning intensity and peritransplant flow cytometric MRD dynamics in adult AML.
Blood
; 139(11): 1694-1706, 2022 03 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995355
2.
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donors.
Blood
; 136(13): 1499-1506, 2020 09 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32603426
3.
Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.
Haematologica
; 106(6): 1599-1607, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32499241
4.
Who Enrolls in an Online Cancer Survivorship Program? Reach of the INSPIRE Randomized Controlled Trial for Hematopoietic Cell Transplantation Survivors.
Biol Blood Marrow Transplant
; 26(10): 1948-1954, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599215
5.
Early Post-Transplantation Spirometry Is Associated with the Development of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(5): 943-948, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31821885
6.
Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(2): 392-400, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31682980
7.
Bone Health Management After Hematopoietic Cell Transplantation: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 26(10): 1784-1802, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32653624
8.
Age and gender differences in financial distress among hematopoietic cell transplant survivors.
Support Care Cancer
; 28(9): 4361-4371, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916007
9.
Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.
Biol Blood Marrow Transplant
; 25(10): 2002-2007, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31260802
10.
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(2): e46-e54, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30481594
11.
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(5): e145-e154, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30521975
12.
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(2): 362-368, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30287390
13.
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease.
Blood
; 130(3): 360-367, 2017 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28495794
14.
Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial.
Biol Blood Marrow Transplant
; 24(2): 308-313, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032276
15.
Quality of Life of Caregivers of Hematopoietic Cell Transplant Recipients.
Biol Blood Marrow Transplant
; 24(11): 2271-2276, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29935213
16.
Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.
Biol Blood Marrow Transplant
; 24(2): 393-399, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29032275
17.
Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.
Biol Blood Marrow Transplant
; 24(2): 373-380, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29051021
18.
Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors.
Biol Blood Marrow Transplant
; 24(8): 1692-1698, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753161
19.
Transplant Conditioning with Treosulfan/Fludarabine with or without Total Body Irradiation: A Randomized Phase II Trial in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(5): 956-963, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29274396
20.
Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.
Biol Blood Marrow Transplant
; 24(6): 1274-1280, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29325830